Abstract: A sacral wound dressing having a bottom end with three substantially V-shaped projections. In use, a protective layer of the wound dressing is removed to expose an adhesive layer and an absorbent layer, the wound dressing is folded over on itself substantially along a central axis, a medial V-shaped projection is inserted into a superior portion of the gluteal cleft of the person to adhere the medial projection to the skin within the gluteal cleft, two lateral V-shaped projections are then pushed against a superior portion of the buttocks of the person to adhere the lateral projections to the skin, and the opposing lateral ends and the top end of the wound dressing are then pushed against the skin of the person until the wound dressing is properly adhered to the sacrococcygeal region over the sacral wound.

Abstract: A bandage for improved wound care is disclosed. The bandage comprises a non-adherent, deformable inner layer, a leak-proof outer layer that is substantially coextensive with the inner layer, and an absorbent middle layer contacting both the inner and outer layers. An adhesive strip and adhesive tabs along the bandage's side attach and adjust the fit of the bandage to securely hold the absorbent layer in contact with the wound, without any adhesive touching the skin, thereby eliminating pain and discomfort upon removal or replacement. The bandage allows substantial freedom of motion without slipping. The adhesive strip and tabs secure the bandage in place without any adhesive touching the skin, thereby providing convenience and causing no pain or discomfort upon removal or replacement of the bandage. The bandage may use a non-stick netting material layer to improve patient comfort, and elastic cuffs to improve fit and leakage.

Abstract: A wound-covering hydrogel material which has excellent stretchability and absorbs exudates from wounds. It can maintain over long a wet environment which is suitable for accelerating the healing of wounds. There is no fear of causing pain or damaging the regenerated skin when the wound-covering hydrogel material is replaced with a fresh one. The wound-covering hydrogel material prepared by spreading a hydrogel comprising a water-soluble semi-synthetic polymer, glycerol and water, on a laminated two-layer film composed of a polyurethane film and hydrophobic fibers. The covering material has a moisture permeability as measured by the cup method in accordance with JIS Z0208 of 500-2,000 (g/m2/24 h).

Abstract: An apparatus for promoting the clotting of blood and controlling bleeding comprises a receptacle for retaining blood clotting material in particulate form therein. A pad for controlling bleeding comprises a mesh structure and a support attached to the mesh structure to facilitate the application of pressure to the pad and the wound. A bandage applicable to a bleeding wound comprises a mesh structure and a flexible substrate attached to the mesh structure, the substrate being a cloth or plastic member that may be adhesively attachable to cover a wound. In any embodiment, at least a portion of the receptacle or mesh structure is defined by a mesh having openings therein, and at least a portion of the particulate blood clotting material is in direct contact with blood. The mesh may include a zeolite powder impregnated or otherwise incorporated therein.

Abstract: A blood clotting substrate and device which has a plurality of oxygen plasma-treated polypropylene pillars extending from the surface of a polypropylene film.

Abstract: Hydrogel compositions are provided (a) that have a continuous hydrophobic phase and a discontinuous hydrophilic phase, (b) that have a discontinuous hydrophilic phase and a continuous hydrophilic phase, or (c) that are entirely composed of a continuous hydrophilic phase. The hydrophobic phase, if present, is composed of a hydrophobic polymer, particularly a hydrophobic pressure-sensitive adhesive (PSA), a plasticizing elastomer, a tackifying resin, and an optional antioxidant. The discontinuous hydrophilic phase, if present, is composed of a crosslinked hydrophilic polymer, particularly a crosslinked cellulosic polymer such as crosslinked sodium carboxymethylcellulose. For those hydrogel compositions containing a continuous hydrophilic phase, the components of the phase include a cellulose ester composition or an acrylate polymer or copolymer, and a blend of a hydrophilic polymer and a complementary oligomer capable of hydrogen bonding thereto.

Abstract: A wound-closing dressing, which is suitable for use as part of a reduced-pressure, wound-treatment system, may include a sealing drape, one or more contracting elements, and a gripping member. The contracting element may be coupled to the sealing drape and is configured to contract when activated and to generate a closing force. A gripping member is coupled to the sealing drape and is configured to transmit the closing force to a patient's epidermis. Other dressings, systems, and methods are also disclosed.

Abstract: A wound treatment apparatus comprises: a fluid drainage tube configured to be coupled to a fluid drainage passageway of a wound bandage; first and second fluid drainage receptacles coupled to the drainage tube; and first and second valves coupled between the fluid drainage tube and the first and second fluid drainage receptacles, respectively.

Abstract: A dehiscence preventive member is adapted to cover up a wound and surrounding tissues. A plurality of holding members are adapted to hold the dehiscence preventive member closely upon the wound and the surrounding tissues, and a contraction preventive member keeping the dehiscence preventive member suitably expanded in a dehiscence direction and of preventing the expanded dehiscence preventive member from contracting. The contraction distance of the dehiscence preventive member in the dehiscence direction is equal to or greater than a contraction distance of the holding member in the dehiscence direction. The dehiscence preventive is closely applied to the wound and surrounding tissues after expansion in the dehiscence direction such that the contraction distance of the dehiscence preventive member in the dehiscence direction is equal to or greater than the contraction distance of the dehiscence preventive member in a direction normal to the dehiscence direction.

Abstract: The invention relates to a wound dressing and to a device for use in negative-pressure wound therapy, in particular for wounds in the abdominal region, and also to methods for producing the device. The wound dressing comprises at least one flexible film for application onto the wound bed, more particularly onto exposed internal organs or onto the greater omentum, and furthermore at least one pocket, which is present on the side of the wound dressing that faces away from the wound during use and which simplifies the uniform application and placement of the wound dressing on the wound bed. The invention furthermore relates to a surgical instrument for applying a wound dressing.

Abstract: A bandage for covering a wound treated with an allograft can include a liquid permeable skin adherent layer having a wound facing surface with an adhesive thereon for adhering to skin proximate the wound. A compressible support section can be supported by the skin adherent layer for maintaining the allograft in place on the wound, and an absorbent section can be positioned over the compressible support section. The absorbent section can be comprised of a liquid absorbent material and can aid in keeping the allograft hydrated. The compressible support section can be positioned intermediate the skin adherent layer and the absorbent section. A liquid permeable covering layer can be positioned over the absorbent section, and attached to the skin adherent layer.

Abstract: A protective cover for a site on a patient is provided which provides an effective moisture barrier to the site. The cover includes a first, absorptive layer which absorbs and wicks away any accumulated moisture on the site to keep the site dry and contaminant free, and a second, waterproof layer which precludes penetration of moisture and other such external effects to keep both the first layer and the site dry. Cuffs formed on open end portions of the second layer direct water and other such contaminants away from potential points of entry, thereby providing a further level of protection to the first layer and the site.

Abstract: A method for treating a wound, and a dressing for wound care management comprising a three-dimensional body of glass-based fibers comprising one or more glass-formers selected from the group consisting of P2O5, SiO2, and B2O3; at least about 25 wt % of the fibers have a diameter between about 200 nm and about 4000 nm, and a length:width aspect ratio of at least about 10. In another form, the glasses are in the form of particles in an ointment or cream applied to a wound. In yet other forms the glasses are employed as fibers formed into sutures for closing a wound, or as particles in a surgical glue for closing a wound.

Abstract: The inventive disclosure contained herein is generally directed to a class of medical bandages that in many embodiments are effective in the treatment of various types of tissue burns, whether be burns due to thermal burns, sun exposure, or rashes. Such products can include a plurality of specialized bandages and wraps that incorporate an extremely thin layer of thermally conductive metal (often aluminum) at the base of a substrate adapted to be in direct contact with a burn wound, while manufacturing the top side of the aluminum substrate to have a heat-dissipation-enhancing topography to help cool burns faster by enhancing thermal-convection properties. The bandage can also feature a thermochromic indicator for users to realize the thermal-cooling status of a burn to which a bandage has been applied.

Abstract: An apparatus for promoting the clotting of blood and controlling bleeding comprises a receptacle for retaining molecular sieve material in particulate form therein. A pad for controlling bleeding comprises a mesh structure and a rigid or semi-rigid support attached to the mesh structure to facilitate the application of pressure to the pad and the wound. A bandage applicable to a bleeding wound comprises a mesh structure and a flexible substrate attached to the mesh structure, the substrate being a cloth or plastic member that may be adhesively attached to cover a wound. In any embodiment, at least a portion of the receptacle or mesh structure is defined by a mesh having openings therein, and at least a portion of the particulate molecular sieve material is in direct contact with blood.

Abstract: The disclosed First Aid Strips are a cost effective and economical method for treating any systemic illness or topical skin condition such as boil, bruise, or burn, using first aid strips, by providing a pouch which provides a means to use medication in the form of cream or gel. The provision of a pouch prevents medication from escaping when applied on the body with an adhesive first aid strip. Thus a measured amount of any medication when applied stays where it is applied and not lost. A ring made of rubber/latex may be used to create the said pouch, when placed on the first aid strip.

Abstract: A wound dressing composition comprising a partially cured polyurethane fluid. The composition can be injected directly into a wound, where it cures to form a wound filling dressing. Also provided is a wound dressing comprising such a composition. Also provided is a kit for the preparation of such wound dressings, the kit comprising (a) a polyurethane prepolymer; and (b) a curing agent for the polyurethane prepolymer. Preferably, the polyurethane components comprise reaction products of a diisocyanate with castor oil or a related ester of ricinoleic acid or its derivatives.

Abstract: A device and method for removing moisture vapor from adjacent skin surfaces such as bariatric skin folds. The device may include a vapor permeable material, a spacer material, and an air mover that are configured to be inserted between adjacent skin surfaces. The device is inserted between adjacent skin surfaces and the air mover is operated to provide air flow through the spacer material.

Abstract: Systems and apparatuses for administering reduced pressure treatment to a tissue site including a wound filler for positioning adjacent a wound site on a patient. The wound filler includes at least one strand having a plurality of nodes positioned along a length of the strand. The at least one strand has a charged state and an uncharged state. In the charged state, the at least one strand includes a stored energy that when released would deform or move the at least one strand. In the discharged state, the stored energy has been released. The wound filler further includes a removable sheath encasing the at least one strand. The at least one strand transitions from the charged state to the uncharged state as the removable sheath is removed.

Abstract: A skin guard apparatus for protecting a part of an anatomy is provided herein. The apparatus includes a covering member configured to correspond to the part of the anatomy, wherein the covering member does not touch the part of the anatomy, a raiser member, the raiser member configured to raise the covering member off the part of the anatomy, and one or more positioning members configured for the part of the anatomy.

Abstract: Reduced-pressure medical dressings, systems, and methods involve a dressing with a first barrier layer that desolidifies when exposed to a fluid—typically a liquid—to form a treatment aperture in the first barrier that is used to deliver reduced pressure to a tissue site. The first barrier layer is formed from a desolidifying material. The system includes a drape covering a second surface of a manifold and a portion of the patient's epidermis to provide a substantially sealed space containing a manifold and the first barrier layer. Other systems, dressings, and methods are also disclosed.

Abstract: A wound dressing is disclosed. The wound dressing includes an oil emulsion and a substrate including a plurality of first yarns and a plurality of second yarns, wherein the plurality of first yarns includes a plurality of first fibers comprising a cellulosic material and the plurality of second yarns includes a plurality of second fibers comprising a non-adherent polymeric material. In other cases, the substrate can be a woven substrate, a nonwoven substrate, or a knitted substrate of nonadherent polymeric fibers or yarns.

Abstract: The various embodiments herein provide an electro spun wound dressing comprising three nano fibrous layers and a method of synthesizing the same. The outer polymeric layer acts as a support layer for the other two layers and is hydrophilic in nature. The middle layer comprises a genipin cross linked reservoir layer loaded with a herbal extract of Melilotus officinalis and is hydrophobic or hydrophilic in nature. The second layer is cross-linked to control a release of the Melilotus officinalis extract in an aqueous environment. The third layer is a wound contacting inner layer comprising a non-cross-linked chitosan based nanofibrous layer that is hydrophilic in nature. Various additives are provided to enhance the mechanical or the chemical properties of the wound dressing and to control a release profile of the herbal extract.

Abstract: A manifold member for use in applying reduced pressure to a tissue site on a patient looks or feels like medical cotton gauze but has a plurality of plurality of interlocking synthetic fibers and a plurality of asperities that provide enhanced performance. Other manifold members, systems, and methods are disclosed.

Abstract: A wound therapy device is disclosed. The wound therapy device may include a housing for covering at least a portion of a wound and for sealing to a body surface of a patient. The housing may also include a liquid collector for retaining liquid therein and a vacuum connection for coupling to a vacuum source. The vacuum connection may be in gaseous communication with the liquid collector. The vacuum connection may be separated from the liquid collector by a liquid barrier.

Abstract: A device for promoting the clotting of blood comprises a clay material in particle form and a receptacle for containing the clay material. At least a portion of the receptacle is defined by a mesh. Another device comprises a gauze substrate and a clay material disposed on the gauze substrate. Another device is a bandage comprising a substrate, a mesh mounted on the substrate, and particles of a clay material retained in the mesh. A hemostatic sponge comprises a substrate, a hemostatic material disposed on a first surface of the substrate, and a release agent disposed on a second surface of the substrate. The release agent is disposed on the wound-contacting surface of the substrate. When treating a bleeding wound, application of the hemostatic sponge causes at least a portion of the hemostatic material to come into contact with blood through the release agent and through the substrate.

Abstract: A system for delivering a medical dressing onto an appendage, such as a finger or penis, of a patient includes a medical dressing defined by a flexible tubular sleeve that is configured to elastically expand radially, and a delivery device including a pair of pivotable spreader arms attached to a handle portion. The spreader arms of the delivery device are configured for insertion within the sleeve to enable radial expansion from a first diameter to a larger second diameter and positioning of the medical dressing onto the desired anatomical area.

Abstract: Wound treatment dressings comprising combinations of at least one conductive layer, at least one absorbent layer or a moisture regulation layer, and methods of making and methods of use are disclosed for treatment of wounds in humans and animals. The novel dressings aid in healing by helping restore the transepithelial potential of the skin, providing a functional anti-microbial barrier, and allowing for regulation of the moisture content of the wound without disturbing the wound.

Abstract: A pad of elastomeric material having a softness of no more than about durometer 50 Shore 00. The pad may carry adhesive and/or a housing for adhering the pad to a surface, either directly or indirectly through an envelope which surrounds the pad and carries the adhesive. Such a pad exhibits hemostatic and leak prevention properties against needle puncture holes in the skin or the wall of a hollow medical device. Particularly, hemostasis may be prevented with low pressure application of the pad to the skin. The pad may be previously applied to the skin of the patient or a wall of a medical device such as tubing or a solution bag, and the needle may then penetrate both the pad and the skin or medical device wall, to make a resealable puncture with leakage reduction and hemostasis when the needle is withdrawn.

Abstract: Wound treatment dressings comprising combinations of at least one conductive layer, at least one absorbent layer or a moisture regulation layer, and methods of making and methods of use are disclosed for treatment of wounds in humans and animals. The novel dressings aid in healing by helping restore the transepithelial potential of the skin, providing a functional anti-microbial barrier, and allowing for regulation of the moisture content of the wound without disturbing the wound.

Abstract: A colored gauze scheme helps locate a gauze pad in low light, resulting in cost savings by minimizing lost gauze. Moreover, the colored gauze scheme can provide a method of matching a color to a particular day, allowing medical staff to quickly identify the day the gauze was applied and quickly identify when to change the gauze, thereby reducing the risk of infection.

Abstract: Optical rods which transmit light exteriorly of their length are coupled to one or more lasers at ends. The optical rods are mounted on various carriers or as part of an optical bandage to provide therapeutic light to a portion of a human body. The lasers may be activated at various times in a 24-hour period, while the optical rods are worn by a user.

Abstract: This invention concerns wound/bandage protectors. In particular, the invention relates to a wound/bandage protector configured as a wrap, a sock/mitten, or a bandage, which may be made out of stretchable material. The wrap may have one or more fastening straps as well as possibly a first catch fastening surface. The sock/mitten may have a fastening strap and a sheath. The WTap, the sock/mitten, and the bandages may have apertures and aperture covers. In addition, the wound/bandage protectors as well as the bandages may have diamond or triangular gauze configurations with the gauze pad having three or fourprimary corners, the primary corners of the gauze pad in most instances being oriented towards edges of the body portion or length or width tangents of the body portion, preferably mid-points or mid-sections of the length or width tangents or body portion edges.

Abstract: A light-weight, semi-rigid wound shield protects wounds and intradermal therapy ports from impacts between therapy sessions. The wound shield comprises a domed cover forming a concave cavity above the wound or therapy port. A flange surrounding the cavity presses against the patient's skin to deflect and distribute the force of impacts. The flange may include a self-adhesive layer on its bottom, or it may be secured with medical tape or a fitted bandage that overlaps the flange and the surrounding skin. A peel-away membrane covers the adhesive layers. A tunnel through the flange may connect to the cavity to accommodate a therapy tube which remains in place while the shield is worn. In an alternate embodiment, a base coextensive with the flange adheres to the patient's skin and the wound shield removably couples to the base by its flange. The assembly comes in a sterile envelope or package.

Abstract: The present invention is directed to a hemostatic textile, comprising: a material comprising a combination of glass fibers and one or more secondary fibers selected from the group consisting of silk fibers; ceramic fibers; raw or regenerated bamboo fibers; cotton fibers; rayon fibers; linen fibers; ramie fibers; jute fibers; sisal fibers; flax fibers; soybean fibers; corn fibers; hemp fibers; lyocel fibers; wool; lactide and/or glycolide polymers; lactide/glycolide copolymers; silicate fibers; polyamide fibers; feldspar fibers; zeolite fibers, zeolite-containing fibers, acetate fibers; and combinations thereof; the hemostatic textile capable of activating hemostatic systems in the body when applied to a wound. Additional cofactors such as thrombin and hemostatic agents such as RL platelets, RL blood cells; fibrin, fibrinogen, and combinations thereof may also be incorporated into the textile. The invention is also directed to methods of producing the textile, and methods of using the textile to stop bleeding.

Abstract: A wound dressing garment is provided. The wound dressing garment includes a wearable garment including a portion having a hole configured to receive a wound dressing therein in combination with the wound dressing. The wound dressing includes a border connecting the wound dressing to the wearable garment where the border extends around the perimeter of the hole to locate the wound dressing therein. The wound dressing may include one or more additional layers including a hydrogel layer. A method for treating wound or preventing bed sores using the wound dressing garment is also provided.

Abstract: Under one aspect, an apparatus includes a primary dressing configured for application over a region of compromised skin and including fluid-absorbing material; and a secondary dressing configured for application over the primary dressing. The secondary dressing applies pressure to the primary dressing so as to maintain the primary dressing in place over the region of compromised skin and promote the flow of fluid from the region of compromised skin into the fluid-absorbing material, and allows moisture in the fluid to evaporate from the fluid-absorbing material. Under another aspect, a dressing includes a fabric layer sized to cover a region of compromised skin; a foam layer secured to the fabric layer and having an aperture defined therein sized to cover the region of compromised skin; and a biocompatible adhesive layer disposed on the foam layer. Methods of applying the dressing also are provided.

Abstract: A wound dressing includes a substrate fabricated from first and second yarns. The first yarns include at least one of a bast fiber, a cellulosic fiber, and combinations thereof and the second yarns include at least one alternative polymeric fiber.

Abstract: An adhesive patch configured to attach an ostomy appliance to a patient includes a peripheral rim disposed around a central hole that is attachable to a stoma of the patient; and a band of adhesive extending from the peripheral rim to an inner border of the adhesive patch and having a pattern of curvilinear indentations extending to the peripheral rim of the patch.

Abstract: Devices, bandages, kits and methods are described that can control or regulate the mechanical environment of a wound to ameliorate scar and/or keloid formation. The mechanical environment of a wound includes stress, strain, and any combination of stress and strain. The control of a wound's mechanical environment can be active, passive, dynamic, or static. The devices are configured to be removably secured to a skin surface in proximity to the wound site and shield the wound from endogenous and/or exogenous stress.

Abstract: A device for promoting the clotting of blood comprises a clay material in particle form and a receptacle for containing the clay material. At least a portion of the receptacle is defined by a mesh. Another device comprises a gauze substrate and a clay material disposed on the gauze substrate. Another device is a bandage comprising a substrate, a mesh mounted on the substrate, and particles of a clay material retained in the mesh. A hemostatic sponge comprises a substrate, a hemostatic material disposed on a first surface of the substrate, and a release agent disposed on a second surface of the substrate. The release agent is disposed on the wound-contacting surface of the substrate. When treating a bleeding wound, application of the hemostatic sponge causes at least a portion of the hemostatic material to come into contact with blood through the release agent and through the substrate.

Abstract: A long term wound dressing with a semi-permeable membrane containing a plurality of raised capillaries with internal capillary channels. A closable aperture, such as a slit, runs parallel to the capillary channels. The closable apertures open upon increased pressure caused by flushing fluid or other fluid between the dressing and the wound, allowing the fluid to drain away from the wound. The long term wound dressing may contain additional apertures for attaching flushing and drainage tubes.

Abstract: The present invention is directed to a hemostatic textile, comprising: a material comprising a combination of glass fibers and one or more secondary fibers selected from the group consisting of silk fibers; ceramic fibers; raw or regenerated bamboo fibers; cotton fibers; rayon fibers; linen fibers; ramie fibers; jute fibers; sisal fibers; flax fibers; soybean fibers; corn fibers; hemp fibers; lyocel fibers; wool; lactide and/or glycolide polymers; lactide/glycolide copolymers; silicate fibers; polyamide fibers; feldspar fibers; zeolite fibers, zeolite-containing fibers, acetate fibers; and combinations thereof; the hemostatic textile capable of activating hemostatic systems in the body when applied to a wound. Additional cofactors such as thrombin and hemostatic agents such as RL platelets, RL blood cells; fibrin, fibrinogen, and combinations thereof may also be incorporated into the textile. The invention is also directed to methods of producing the textile, and methods of using the textile to stop bleeding.

Abstract: A wound treatment device comprises a wound surface contacting plug (10) and a cover (24) for covering the wound surface (22) and the plug (10), wherein said plug (10) consists of a flat textile isolating material comprising at least one first surface layer (12), one second surface layer (14) and one intermediate space (18) arranged between said surface layers (12, 14). At least the first surface layer (12) is provided with a biocompatible surface and a structure which enables a liquid to pass and prevents a wound tissue from growing in said structure. The intermediate space (18) is provided with isolating threads (16) elastically holding the first surface layer (12) and the second surface layer at a certain distance from each other.

Abstract: The inventive disclosure contained herein is generally directed to a class of medical bandages that in many embodiments are effective in the treatment of various types of tissue burns, whether be burns due to thermal burns, sun exposure, or rashes. Such products can include a plurality of specialized bandages and wraps that incorporate an extremely thin layer of thermally conductive metal (often aluminum) at the base of a substrate adapted to be in direct contact with a burn wound, while manufacturing the top side of the aluminum substrate to have a heat-dissipation-enhancing topography to help cool burns faster by enhancing thermal-convection properties. The bandage can also feature a thermochromic indicator for users to realize the thermal-cooling status of a burn to which a bandage has been applied.

Abstract: Provided is a further improved wound dressing suitable for a method for treating a wound while maintaining a moist environment created by exudate oozing from the wound. The wound dressing (5) comprises at least three layers including a first layer, a second layer and a third layer in order from the side used in contact with a wound site, which layers are integrally stacked together. The first layer (1) comprises a resin sheet material having a number of pores penetrating in a thickness direction. The second layer (2) comprises a sheet material of which the surface is water-repellent and becomes water-permeable when pressure is applied. The third layer (3) comprises a sheet material capable of absorbing and holding water. The wound dressing optionally comprises a fourth layer comprising a resin film, a fabric or a nonwoven.

Abstract: A wound shield to manage repetitive access stress may include a conformable substrate to circumscribe a wound. Any suitable dressing may be secured to the conformable substrate providing separation between the wound and the dressing. The wound substrate may provide a site for attachment of adhesive dressings to shield the patient's skin from the pain of repetitive access and or removal of the dressings. A conformable substrate may be composed of one or more layers of any suitable material and may include adhesive on one or more surfaces to secure the substrate to the wound site and or to secure the dressing to the conformable substrate. A wound substrate may include strong adhesive to secure the substrate to the patients skin. The conformable wound substrate will be formed of any suitable non-absorbent material to permit long term application adjacent a wound. Thus many dressings may be applied and removed from a single wound substrate shielding the patient's skin from repetitive insult.

Abstract: A bandage for aborting an infection caused by staph bacterium (a “staph spot”) at its incipient stage preventing the emergence of a boil, comprising: a pad having a central aperture; an adhesive covering strip long enough to cover the pad attached to the top thereof at only one point for attachment to the subject's skin having a width less than that of the central aperture to form an air chamber and at least one tunnel which passes through the wall of the pad from outside to inside to the central aperture. The bandage is used by affixing the pad and one end of the adhesive covering strip to the skin, with the central aperture encircling the staph spot without touching it and taping down the other end of the strip for affixing the strip at both its ends from atop the pad onto the subject's skin.

Abstract: A method for wound-healing is disclosed where the method comprises providing a housing forming a cavity, the cavity comprising at least one opening configured to encompass at least a portion of a wound region of a patient. The method includes sealing a perimeter of the at least one opening to a surface of the patient proximate the wound region and absorbing a wound fluid in the cavity. A chamber is provided in communication with the cavity, and would fluid is electrochemically removed from the cavity into the chamber.

Abstract: A microfibrillar cellulose substrate having a defined morphology and optimized concentrations of free radicals formed by milling a source material containing alpha cellulose with non-metalic cutting surfaces into a sterilized fine powder with a particle size of approximately 20 to 35 micrometers. A gauze selected from the group consisting of a woven, nonwoven, and extruded netting substrate for supporting the microfibrillar cellulose substrate. The microfibrillar cellulose substrate may be carried between a first layer of the gauze and a second layer of the gauze by affixing the first and second gauze layers closed around their perimeter.